§ Funding Round
Series C funding round for Avalyn Pharma raising $180M in September 2023
Series C funding round for Avalyn Pharma raising $180M in September 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
SR OneLEAD | — | — |
| Angel | heather preston | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | gianna hoffman-luca | |
| Organization | — | |
RiverVest Venture Partners | — | — |
| Organization | — | |
Surveyor Capital | — | — |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$316M
Top Valuation
-
Avalyn Pharma raised $180M in a Series C round.
The round was announced on 09/01/23.
The round was led by SR One, eventide asset management, gianna hoffman-luca.
